CODA Biotherapeutics Company
CODA Biotherapeutics is developing a novel chemogenetic platform to modulate neuronal activity.
Headquarters:
South San Francisco, California, United States
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Technology:
Others
Founded Date:
2014
Industry:
Gene Therapy